Active Trials Closed for Recruitment
Active Trials listed below are clinical trials closed to recruitment but the study is ongoing in that participants are receiving an intervention or being examined. Please click on the links below for further information about trials currently closed for recruitment.
01.07 WBRTMel
01.09 RTN2
01.12 EAGLE FM
03.12 MelMarT Pilot
04.17 SMARTI
01.15 CHARLI
02.12 RADICAL
01.07 WBRTMel
Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma – A randomised Phase III trial
Chair
Professor Gerald Fogarty
Registration ID
Trial Status
Active Trial Closed for Recruitment
MASC Trials Contact
01.09 RTN2
A randomised trial of post-operative radiation therapy following wide excision of neurotropic melanoma of the head and neck
Chair
Associate Professor Matthew Foote
Registration ID
Trial Status
Active Trial Closed for Recruitment
MASC Trials Contact
01.12 EAGLE FM
Evaluation of groin lymphadenectomy extent for metastatic melanoma - A randomised phase III trial to evaluate survival, morbidity, and quality of life
Chair
Professor Andrew Spillane
Registration ID
Trial Status
Active Trial Closed for Recruitment
MASC Trials Contact
03.12 MelMarT Pilot
A Phase III, multi-centre, multi-national randomised control trial investigating 1cm vs 2cm excision margins for primary cutaneous melanoma
Chair
Professor Michael Henderson and Professor Mark Moncrieff
Registration ID
Trial Status
Active Trial Closed for Recruitment
MASC Trials Contact
04.17 SMARTI
A Pilot Study of an Artificial Intelligence System as a Diagnostic Aide for Better Skin Cancer Management
Chair
Associate Professor Victoria Mar
Registration ID
Trial Status
Active Trial Closed for Recruitment
MASC Trials Contact
01.15 CHARLI
A Phase Ib/II Trial of Ipilimumab-Nivolumab-Denosumab and Nivolumab-Denosumab in Patients with Unresectable Stage III and IV Melanoma
Chair
Associate Professor Shahneen Sandhu
Registration ID
Trial Status
Active Trial Closed for Recruitment
MASC Trials Contact
02.12 RADICAL
A randomised controlled multicentre trial of imiquimod versus radiotherapy for lentigo maligna when staged surgical excision with 5mm margins is not possible, is refused, or fails
Chair
Associate Professor Pascale Guitera
Registration ID
Trial Status
Active Trial Closed for Recruitment
MASC Trials Contact